This article is more than 5 years old. Information may no longer be current.

SeaSpine launches new interbody device

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SeaSpine Holdings Corporation recently announced the launch of its Ventura NanoMetalene transforaminal intervertebral body fusion device, according to a company release.

The commercially available interbody transforaminal device has been successfully implanted and is indicated as an adjunct to fusion in patients with degenerative disc disease (DDD). The device is made with NanoMetalene, an ultra-thin layer of commercially pure titanium molecularly bonded to a Peek-Optima implant, according to the company.

The device’s convex surfaces and multiple footprints allow surgeons to create a secure anatomical fit, and Ventura NanoMetalene’s large graft aperture for autogenous bone graft assists in fusion. Ventura NanoMetalene is optimal for both open and minimally transforaminal lumbar intervertebral fusion procedures, according to the company.

SeaSpine Holdings Corporation has received FDA 510(K) clearance for several NanoMetalene-coated PEEK interbody devices that are expected to roll out commercially in the future. 

Reference: www.seaspine.com